首页 | 本学科首页   官方微博 | 高级检索  
     

千金藤立定治疗迟发性运动障碍30例
引用本文:蔡能,金国章,张振德. 千金藤立定治疗迟发性运动障碍30例[J]. 中国新药与临床杂志, 1989, 0(1)
作者姓名:蔡能  金国章  张振德
作者单位:上海市精神卫生中心,中国科学院上海药物研究所,中国科学院上海药物研究所 上海 200030,上海 200031,上海 200031
摘    要:在原有抗精神病药治疗情况下,合用-千金藤立定(SPD)治疗迟发性运动障碍(TD)30例。SPD剂量50mg tid,一个疗程8wk。结果显效率23%,总有效率56%;大多数4wk内生效,亦有8wk才生效。SPD无明显副作用,未增多或加重抗精神病药副作用,精神病症状也未恶化。初步认为SPD治疗TD安全有效。

关 键 词:l-千金藤立定  多巴胺受体  迟发性运动障碍

Therapeutic effect of l-stephoiidine on 30 patients with tardive dyskinesia
CAI Neng. Therapeutic effect of l-stephoiidine on 30 patients with tardive dyskinesia[J]. Chinese Journal of New Drugs and Clinical Remedies, 1989, 0(1)
Authors:CAI Neng
Abstract:Thirty patients with tardive dyskinesia(TD) were treated by l-stepho-lidine(SPD).Each patient received SPD 50 mg tid for 8 wk, and antipsychotic drugs and their dosages that caused TD were unchanged during the course of SPD treatment.The therapeutic effect was excellent in 7 patients (23%),with overall effect in 17 patients (56%); SPD gave effect to TD in most of them within 4 wk but in some patients even at wk 8.During the course of treatment, SPD was found neither to propuce apparent side effect nor to increase the side effects of antipsychotic drugs, and psychotic symptoms did not relapse or aggravate.Preliminary result indicated that SPD is safe and effective in clinical treatment of TD.
Keywords:l-stepholidine  dopamine receptor  tardive dyskinesia
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号